4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-22-064008
Chief Financial Officer bought 39,000 shares at $0.29 ($11,326)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wood Gavin Chief Financial Officer | 2022-05-20 | Purchase | +39,000 | $0.29 | $11,326 | 96,000 | D |
| Open-market purchases · 39,000 sh · avg $0.29 · $11,326 | |||||||
Loading xslF345X03/tm2216620-1_4seq1.xml…